Literature DB >> 1597296

Vascular occlusion of the retina--an experimental model. II. Platelet aggregates.

H Schroer1, G Scheurer, W Behrens-Baumann.   

Abstract

Using a new technique to mimic arteriolar occlusion syndromes, different microparticles were injected into the ophthalmic artery of pigs. These microparticles were platelet aggregates of various sizes ranging from 0.15 mm to more than 0.8 mm. Aggregation was induced using adenosine diphosphate and thrombin. In some experiments, acetylsalicylic acid and histamine were also applied. In a further series of experiments, mixed aggregates containing platelets and leukocytes were injected. The results were observed by indirect ophthalmoscopy and consisted of superficial and deep retinal infarction. Large platelet aggregates resulted in arterial branch occlusion, whereas mixed and small platelet aggregates produced occlusion of small arterioles. This technique seems to be valuable in studying retinal arteriolar occlusion syndromes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1597296     DOI: 10.1007/bf00176305

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  25 in total

1.  [Purtscher disease. Range of variation of clinical manifestations in 11 patients and pathogenetic considerations].

Authors:  W Behrens-Baumann; G Scheurer
Journal:  Klin Monbl Augenheilkd       Date:  1991-02       Impact factor: 0.700

2.  Thrombin-induced disseminated intravascular coagulation in the dog. I: Demonstration of microthrombi in lung.

Authors:  J Jastrzebski; R N Arnot; P Hilgard; M K Sykes
Journal:  Br J Anaesth       Date:  1975-06       Impact factor: 9.166

3.  Branch retinal artery occlusion after platelet transfusion.

Authors:  C M Greven; E van Rens; M M Slusher
Journal:  Am J Ophthalmol       Date:  1990-01-15       Impact factor: 5.258

Review 4.  Vascular occlusion of the retina: an experimental model. I. Leukocyte aggregates.

Authors:  G Scheurer; G Praetorius; B Damerau; W Behrens-Baumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

5.  Editorial: Why aspirin?

Authors:  P W Majerus
Journal:  Circulation       Date:  1976-09       Impact factor: 29.690

6.  Potentiation of complement (C5a)-induced granulocyte aggregation by cytochalasin B.

Authors:  P R Craddock; J G White; H S Jacob
Journal:  J Lab Clin Med       Date:  1978-03

Review 7.  Complement-induced granulocyte aggregation: an unsuspected mechanism of disease.

Authors:  H S Jacob; P R Craddock; D E Hammerschmidt; C F Moldow
Journal:  N Engl J Med       Date:  1980-04-03       Impact factor: 91.245

8.  Histamine stimulate prostacyclin synthesis in cultured human umbilical vein endothelial cells.

Authors:  N L Baenziger; L E Force; P R Becherer
Journal:  Biochem Biophys Res Commun       Date:  1980-02-27       Impact factor: 3.575

9.  Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy.

Authors:  L Weinstein
Journal:  Am J Obstet Gynecol       Date:  1982-01-15       Impact factor: 8.661

10.  Aggregation of leukocytes induced by the complement-derived peptides C3a and C5a and by three synthetic formyl-methionyl peptides.

Authors:  B Damerau; E Grünefeld; W Vogt
Journal:  Int Arch Allergy Appl Immunol       Date:  1980
View more
  7 in total

1.  Pathogenesis of Purtscher's retinopathy. An experimental study.

Authors:  W Behrens-Baumann; G Scheurer; H Schroer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

Review 2.  Vascular occlusion of the retina: an experimental model. I. Leukocyte aggregates.

Authors:  G Scheurer; G Praetorius; B Damerau; W Behrens-Baumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

3.  Complement Factor H Mutation W1206R Causes Retinal Thrombosis and Ischemic Retinopathy in Mice.

Authors:  Delu Song; Yoshiyasu Ueda; Rupak Bhuyan; Imran Mohammed; Takashi Miwa; Damodar Gullipali; Hangsoo Kim; Lin Zhou; Ying Song; Hannah Schultz; Albert Bargoud; Joshua L Dunaief; Wen-Chao Song
Journal:  Am J Pathol       Date:  2019-02-01       Impact factor: 4.307

4.  [Correlation of retinal thickness with the extent of Purtscher's retinopathy].

Authors:  H M Holak; N H Holak; C Schenk; A Olinger; S A Holak
Journal:  Ophthalmologe       Date:  2006-09       Impact factor: 1.059

5.  Anti-platelet effects of anti-glaucomatous eye drops: an in vitro study on human platelets.

Authors:  Marilita M Moschos; Giannis A Moustafa; Vasiliki D Papakonstantinou; Michael Tsatsos; Konstantinos Laios; Smaragdi Antonopoulou
Journal:  Drug Des Devel Ther       Date:  2017-04-19       Impact factor: 4.162

6.  Reversal of threatening blindness after initiation of eculizumab in Purtscher-like retinopathy secondary to atypical hemolytic uremic syndrome.

Authors:  J E Ramos de Carvalho; R O Schlingemann; M Oranje; F J Bemelman; M J van Schooneveld
Journal:  Int Ophthalmol       Date:  2017-03-08       Impact factor: 2.031

Review 7.  Animal Models Used to Simulate Retinal Artery Occlusion: A Comprehensive Review.

Authors:  Nanna Vestergaard; Lasse Jørgensen Cehofski; Bent Honoré; Kristian Aasbjerg; Henrik Vorum
Journal:  Transl Vis Sci Technol       Date:  2019-08-15       Impact factor: 3.283

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.